journal article·2024

Vaporization phosphorization-mediated synthesis of phosphorus-doped TiO 2 nanocomposites for combined photodynamic and photothermal therapy of renal cell carcinoma

Zhuo Song, Chen Guan, Tianyang Li, Chenyu Li, Ningxin Zhang, Ke Liu, Chengyu Yang, Yukun Zhu, Yan Xu

Journal of Materials Chemistry B· Volume 12· Issue 16
Publisher page

Abstract

Clear cell renal cell carcinoma (ccRCC) is a disease with high incidence and poor prognosis. The conventional treatment involves radiotherapy and chemotherapy, but chemotherapeutic agents are often associated with side effects, i.e., cytotoxicity to nontumor cells. Therefore, there is an urgent need for the development of novel therapeutic strategies for ccRCC. We synthesized spherical P/TiO2 nanoparticles (P/TiO2 NPs) by vaporization phosphorization (VP). X-ray photoelectron spectroscopy (XPS) and ultraviolet-visible diffuse reflectance spectroscopy (UV-Vis DRS) analyses confirmed that the anatase TiO2 surface was successfully doped with phosphorus and produced a large number of oxygen vacancies (OV). Serving as a photosensitizer, P/TiO2 NPs not only extended the photoresponse range to the near-infrared II region (NIR II) but also introduced a donor energy level lower than the TiO2 conduction band, narrowing the band gap, which could facilitate the migration of photogenerated charges and trigger the synergistic treatment of photodynamic therapy (PDT) and photothermal therapy (PTT). During NIR irradiation in vitro, the P/TiO2 NPs generated local heat and various oxygen radicals, including 1O2, ˙O2-, H2O2, and ˙OH, which damaged the ccRCC cells. In vivo, administration of the P/TiO2 NPs + NIR reduced the tumor volume by 80%, and had the potential to inhibit tumor metastasis by suppressing intratumor neoangiogenesis. The P/TiO2 NPs showed superior safety and efficacy relative to the conventional chemotherapeutic agent used in ccRCC treatment. This study introduced an innovative paradigm for renal cancer treatment, highlighting the potential of P/TiO2 NPs as safe and effective nanomaterials and presenting a compelling new option for clinical applications in anticancer therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Photocatalysis Techniques · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Nephrology, the Affiliated Hospital of Qingdao University, Qingdao 266003, China

Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität München, Munich, Germany

School of Environmental Science and Engineering, Qingdao University, Qingdao 266071, China

Funding

Qingdao Key Health Discipline Development Fund · National Natural Science Foundation of China · Taishan Scholar Project of Shandong Province

References (42)

Show source-provided references
1. Sung · Ca-Cancer J. Clin. · 2021 · 71 · 20910.3322/caac.21660 ↗
2. Makino · Cancers · 2022 · 14 · 405910.3390/cancers14164059 ↗
3. Bukavina · Eur. Urol. · 2022 · 82 · 52910.1016/j.eururo.2022.08.019 ↗
4. Motzer · J. Natl. Compr. Cancer Network · 2022 · 20 · 7110.6004/jnccn.2022.0001 ↗
5. Choueiri · N. Engl. J. Med. · 2017 · 376 · 35410.1056/NEJMra1601333 ↗
6. Ridyard · Eur. Urol. Focus · 2019 · 5 · 93510.1016/j.euf.2019.03.020 ↗
7. Franzin · Front. Immunol. · 2020 · 11 · 57427110.3389/fimmu.2020.574271 ↗
8. Kong · Int. J. Nanomed. · 2022 · 17 · 642710.2147/IJN.S388996 ↗
9. Agostinis · Ca-Cancer J. Clin. · 2011 · 61 · 25010.3322/caac.20114 ↗
10. de Santana · Colloids Surf., B · 2020 · 196 · 11129710.1016/j.colsurfb.2020.111297 ↗
11. Li · Nat. Rev. Clin. Oncol. · 2020 · 17 · 65710.1038/s41571-020-0410-2 ↗
12. Chia · Cancers · 2023 · 15 · 34610.3390/cancers15020346 ↗
13. Shakil · Int. J. Radiat. Oncol., Biol., Phys. · 1999 · 43 · 85910.1016/S0360-3016(98)00516-1 ↗
14. Yang · Small · 2021 · 17 · e210183710.1002/smll.202101837 ↗
15. Zhang · Colloids Surf., B · 2017 · 160 · 34510.1016/j.colsurfb.2017.09.045 ↗
16. Fujishima · Nature · 1972 · 238 · 3710.1038/238037a0 ↗
17. Wilson · Photochem. Photobiol. · 1985 · 42 · 15310.1111/j.1751-1097.1985.tb01554.x ↗
18. Sun · Biomaterials · 2022 · 291 · 12187510.1016/j.biomaterials.2022.121875 ↗
19. Wang · J. Mater. Chem. B · 2023 · 11 · 831510.1039/D3TB00668A ↗
20. Ziental · Nanomaterials · 2020 · 10 · 38710.3390/nano10020387 ↗
21. Zhang · J. Mater. Chem. B · 2018 · 6 · 234710.1039/C8TB00308D ↗
22. Xu · J. Colloid Interface Sci. · 2023 · 654 · 143110.1016/j.jcis.2023.10.145 ↗
23. Liu · J. Mater. Chem. B · 2019 · 7 · 692410.1039/C9TB01573F ↗
24. Takeda · BioFactors · 2004 · 21 · 34510.1002/biof.552210167 ↗
25. Zhang · Appl. Catal., B · 2019 · 258 · 11798010.1016/j.apcatb.2019.117980 ↗
26. Zhao · Adv. Healthcare Mater. · 2023 · 12 · e220199510.1002/adhm.202201995 ↗
27. Shao · Nat. Commun. · 2016 · 7 · 1296710.1038/ncomms12967 ↗
28. Cui · Int. J. Miner., Metall. Mater. · 2022 · 29 · 222110.1007/s12613-021-2332-0 ↗
29. Guan · J. Appl. Phys. · 2013 · 114 · 11430210.1063/1.4821140 ↗
30. Guan · Adv. Opt. Mater. · 2024 · 230331810.1002/adom.202303318 ↗
31. Wang · Sep. Purif. Technol. · 2024 · 340 · 12673310.1016/j.seppur.2024.126733 ↗
32. Sikandaier · Chin. J. Struct. Chem. · 2024 · 43 · 10024210.1016/j.cjsc.2024.100242 ↗
33. Zhu · Adv. Funct. Mater. · 2024 · 34 · 231162310.1002/adfm.202311623 ↗
34. Zhou · Angew. Chem. · 2022 · 61 · e20221219610.1002/anie.202212196 ↗
35. Liu · Environ. Sci. Technol. · 2023 · 57 · 1245310.1021/acs.est.3c03441 ↗
36. Iwase · Appl. Catal., B · 2013 · 140–141 · 32710.1016/j.apcatb.2013.04.018 ↗
37. Sun · Angew. Chem., Int. Ed. · 2015 · 54 · 1152610.1002/anie.201506154 ↗
38. Zhang · J. Mater. Chem. B · 2023 · 11 · 968510.1039/D3TB01887C ↗
39. Hannon · Adv. Ther. · 2021 · 4 · 200026710.1002/adtp.202000267 ↗
40. Hashemi Goradel · J. Cell. Physiol. · 2018 · 233 · 290210.1002/jcp.26029 ↗
41. Gupta · Semin. Cancer Biol. · 2021 · 69 · 30710.1016/j.semcancer.2020.03.015 ↗
42. Kessenbrock · Cell · 2010 · 141 · 5210.1016/j.cell.2010.03.015 ↗